These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1021 related items for PubMed ID: 12746843

  • 1. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M.
    Prostate; 2003 Jun 15; 56(1):23-9. PubMed ID: 12746843
    [Abstract] [Full Text] [Related]

  • 2. Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Nishimoto K, Nakashima J, Hashiguchi A, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Oya M, Murai M.
    Int J Urol; 2008 Jun 15; 15(6):520-3. PubMed ID: 18422574
    [Abstract] [Full Text] [Related]

  • 3. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan 15; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR.
    J Urol; 2000 Dec 15; 164(6):1982-6. PubMed ID: 11061896
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2005 Mar 15; 12(3):270-4. PubMed ID: 15828954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.
    BJU Int; 2012 Jul 15; 110(1):36-42. PubMed ID: 22085203
    [Abstract] [Full Text] [Related]

  • 12. Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinically localized prostate cancer?
    Giannarini G, Scott CA, Moro U, Pertoldi B, Beltrami CA, Selli C.
    Urol Oncol; 2008 Jul 15; 26(4):353-60. PubMed ID: 18367100
    [Abstract] [Full Text] [Related]

  • 13. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2000 Nov 15; 164(5):1596-600. PubMed ID: 11025712
    [Abstract] [Full Text] [Related]

  • 14. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR.
    J Urol; 2001 Mar 15; 165(3):851-6. PubMed ID: 11176485
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
    Custovic Z, Kraus O, Tomaskovic I, Tarle M.
    Anticancer Res; 2007 Mar 15; 27(4C):2817-21. PubMed ID: 17695453
    [Abstract] [Full Text] [Related]

  • 20. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO.
    J Urol; 2005 Sep 15; 174(3):898-902. PubMed ID: 16093983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.